Intramural hematoma (IMH) tends to occur in a fibrous plaque secondary to balloon dilatation or stent implantation. They are one of the important causes of unexplained deterioration in coronary flows during percutaneous coronary interventions. These IMHs are barely visible on routine coronary angiograms. In an optical coherence tomography (OCT) image, they give rise to a double-lumen appearance with a glistening intimomedial membrane separating the false and the true lumen \[[Figure 1](#F1){ref-type="fig"}\].

![Optical coherence tomography appearance of intramural hematomas. Panel A shows the longitudinal layout with cross-section images at three levels (i, ii, and iii). A biovascular scaffold was used. A-ii (\*)-intimal flap. A-iii (\*)-crescent shaped intramural hematoma, and A-iii (arrow)-intimomedial membrane. Panel B 3D optical coherence tomography T-reconstruction, arrow-the entry site of intramural hematomas, \*-extent of intramural hematoma. Panel C cross-section optical coherence tomography image, \*-exit site. Panel D arrow-intimomedial membrane, \*-hematoma](HV-20-32-g001){#F1}

OCT may not reveal the extramural extent of IMH, which is better visualized in intravascular ultrasound (IVUS), where the IMH appears as an echogenic crescent-shaped blood collection in the extravascular space between the internal and external elastic membrane \[[Figure 2](#F2){ref-type="fig"}\].

![Intravascular ultrasound appearance of intramural hematomas. Panel A double-headed arrow-the longitudinal extent of the intramural hematoma along with cross-section images at four levels from proximal to distal (i, ii, iii, and iv) A-ii (\*)-intramural hematoma, A-iii to iv (arrow)-extramural extent. Panel B \*-intramural hematoma. Panel C arrow-shows the angiographic "neo-stenosis" observedjust distal the stent-edge after its deployment. Panel D \*-echogenic crescent-shaped blood collection, arrow-external elastic membrane](HV-20-32-g002){#F2}

In addition to the extent of the IMH, the entry and exit sites can be studied with IVUS as well as OCT. Such IMHs need to be addressed with stents of sufficient length to cover the entire extent of the IMH.\[[@ref1]\]
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